The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 14th 2025
The announcement came shortly before updated results from the SURMOUNT-5 clinical trial, which found Zepbound had superior weight-loss effects over Wegovy.
Study: Milk Allergy Guidelines May Cause Overdiagnosis in Babies, Children
April 17th 2020Researchers have found that approximately 1% of children have an allergy to cow’s milk, but up to 14% of families believe their children may have the condition, pointing to official guidelines for detecting cow’s milk allergy as a possible cause for the overdiagnosis.
Read More
Survey Shows Adopting New Vancomycin Guidelines is Priority for Pharmacists Despite Pandemic
April 16th 2020A survey conducted between March 30 to April 6 by InsightRx found that implementing the new vancomycin guidelines into the pharmacy community is as important as the coronavirus disease 2019 (COVID-19) in the healthcare system.
Read More
Patients With Lupus Experiencing Difficulties Accessing Hydroxychloroquine, Chloroquine
April 15th 2020Patients with lupus are experiencing difficulties in accessing medications hydroxychloroquine and chloroquine, 2 medications currently being investigated as potential treatment for the coronavirus 2019 disease.
Read More
Relief Fund to Support Pharmacy Professionals Impacted by COVID-19
April 15th 2020Parata Systems has launched the Pharmacy Employee Relief Fund with an initial commitment of $100,000 to support employees of retail, long-term care, hospital, and direct-to-home pharmacies across the United States affected by the coronavirus disease 2019.
Read More
Research Shows Vitamin D Supplements Do Not Prevent Osteoporotic Fractures
April 15th 2020Although vitamin D helps the body absorb minerals essential for bone health, previous studies have found conflicting evidence on whether low vitamin D levels actually increase the risk of osteoporotic fractures and whether vitamin D supplements can reduce the risk.
Read More
Study Examining Higher Chloroquine Doses in COVID-19 Halted Early Due to Safety Concerns
April 14th 2020A study based in Brazil has been halted early for safety reasons after patients with coronavirus disease 2019 taking a higher dose of chloroquine developed irregular heart rates that increased their risk of a potentially fatal heart arrhythmia.
Read More
Limited Global Supply, Ethical Concerns Could Curb Use of Antimalarials Against COVID-19
April 13th 2020Although chloroquine and hydroxychloroquine have been touted as potential treatments for COVID-19, physicians in Italy have warned that the global supply may not be able to keep up with demand.
Read More